We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow %
92.95%
Top 10 Hldgs %
42.01%
Holding
143
New
143
Increased
–
Reduced
–
Closed
–

Top Buys

1
HUM icon
Humana
HUM
+$10.2M
2
DVA icon
DaVita
DVA
+$6.77M
3
UNH icon
UnitedHealth
UNH
+$6.72M
4
PNTG icon
Pennant Group
PNTG
+$5.2M
5
CAH icon
Cardinal Health
CAH
+$3.95M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 67.79%
2 Financials 23.65%
3 Energy 1.95%
4 Materials 1.84%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
101
CALL
Ocular Therapeutix
OCUL
$1.96B
$103K 0.09%
+313
New +$3.05K
ZVRA icon
102
Zevra Therapeutics
ZVRA
$755M
$101K 0.08%
+12,831
New +$110K
NVO
103
CALL
Novo Nordisk
NVO
$223B
$93.5K 0.08%
+536
New +$58K
MRNA icon
104
CALL
Moderna
MRNA
$24.5B
$84.7K 0.07%
+134
New +$6.41K
ORIC icon
105
Oric Pharmaceuticals
ORIC
$1.11B
$76.8K 0.06%
+7,373
New +$67.6K
BMEA icon
106
PUT
Biomea Fusion
BMEA
$92.5M
$76.3K 0.06%
+215
New +$1.71K
RKT icon
107
CALL
Rocket Companies
RKT
$41.1B
$74.3K 0.06%
+618
New +$9.2K
NKTR icon
108
CALL
Nektar Therapeutics
NKTR
$2.31B
$73.4K 0.06%
+104
New +$1.83K
FOLD
109
CALL
DELISTED
Amicus Therapeutics
FOLD
$68.2K 0.06%
+303
New +$3.15K
ELDN icon
110
Eledon Pharmaceuticals
ELDN
$314M
$67.1K 0.06%
+14,855
New +$58.6K
GOSS icon
111
Gossamer Bio
GOSS
$83.2M
$65.5K 0.05%
+65,894
New +$56.5K
EWTX icon
112
CALL
Edgewise Therapeutics
EWTX
$4.28B
$60K 0.05%
+100
New +$3.18K
TERN
113
DELISTED
Terns Pharmaceuticals
TERN
$57.1K 0.05%
+12,807
New +$86.7K
VERV
114
CALL
DELISTED
Verve Therapeutics
VERV
$57K 0.05%
+268
New +$1.51K
APGE icon
115
CALL
Apogee Therapeutics
APGE
$10.1B
$54.5K 0.05%
+54
New +$2.75K
COIN icon
116
CALL
Coinbase
COIN
$41.4B
$45.6K 0.04%
+31
New +$7.87K
CADL icon
117
Candel Therapeutics
CADL
$746M
$42.7K 0.04%
+6,046
New +$35.7K
MODV
118
DELISTED
ModivCare
MODV
$35K 0.03%
+8,757
New +$139K
CMRX
119
DELISTED
Chimerix, Inc.
CMRX
$34.7K 0.03%
+8,813
New +$12.4K
SOFI icon
120
CALL
SoFi Technologies
SOFI
$22.2B
$34K 0.03%
+360
New +$4.68K
NVO
121
PUT
Novo Nordisk
NVO
$223B
$33.5K 0.03%
+490
New +$53K
AFRM icon
122
CALL
Affirm
AFRM
$25.5B
$32.2K 0.03%
+93
New +$5.17K
GOSS icon
123
CALL
Gossamer Bio
GOSS
$83.2M
$24.6K 0.02%
+778
New +$667
RLAY icon
124
CALL
Relay Therapeutics
RLAY
$4.34B
$24.2K 0.02%
+303
New +$1.65K
UBX
125
CALL
DELISTED
Unity Biotechnology
UBX
$23.4K 0.02%
+425
New +$528
2 3 4
5
6

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Persistent Asset Partners, which disclosed 143 positions worth $121M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Humana: 38,160 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, followed by Financials and Energy.

  • Persistent Asset Partners's largest Q4 2024 buy was Humana: 38,160 shares worth $11.2M.
  • Persistent Asset Partners's ten largest holdings make up 42% of its $121M portfolio in Q4 2024.
  • Persistent Asset Partners disclosed 143 positions in Q4 2024, its first 13F filing on record.

Based on Persistent Asset Partners's 13F filing for Q4 2024, filed 14 Feb 2025.